Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-04-26

FDA Approved: DIANEAL PD-2 WITH DEXTROSE — Supplemental Application (Vantive US Healthcare LLC)

View source ↗

Summary

The FDA approved a supplemental application for Dianeal PD-2 with Dextrose, a peritoneal dialysis solution, with manufacturing by Vantive US Healthcare LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIANEAL PD-2 WITH DEXTROSE (Sodium chloride; Sodium lactate; Calcium chloride; Magnesium chloride; Dextrose)

Snippet

SUPPL AP for DIANEAL PD-2 WITH DEXTROSE (SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE)